| | | | | | | | | | |
| |
|
|
| Dockets Entered
On March 15, 2007
|
|
|
|
|
|
|
| |
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
| |
|
|
| 2002E-0343
|
| Patent Term Application for Zevalin No. 5,776,456
|
| |
|
|
| 2003E-0250
|
| Patent Extension for Invanz (ertapenem sodium), 5,478,820
|
| |
|
|
| 2003E-0254
|
| Patent Extension for Inspra (eplerenone), 4,559,332
|
| |
|
|
| 2003E-0257
|
| Patent Extension for Neotame, 5,480,668
|
| |
|
|
| 2003E-0458
|
| Patent Extension, Velcade, bortezomib, #5,780,454
|
| |
|
|
| 2003N-0573
|
| Draft Animal Cloning Risk Assessment
|
| |
|
|
| 2004E-0023
|
| Patent extension application 5,849,911 for Reyataz ( atazanavir sulfate )
|
| |
|
|
| 2004E-0040
|
| Patent Extension for CYDECTIN, U.S. Patent No. 4,916,154
|
| |
|
|
| 2005E-0249
|
| Patent Term Extension Application for Enablex, U.S. Patent No. 5,096,890
|
| |
|
|
| 2006M-0384
|
| Premarket Approval: BP050009 / 0 SURE CHECK HIV 1/2 ASSAY
|
| |
|
|
| 2006M-0385
|
| Premarket Approval: BP050010 / 0 HIV 1/2 STAT-PAKT ASSAY
|
| |
|
|
| 2006M-0386
|
| Premarket Approval: BP050030 / 0 ADVIA Centaur HIV 1/O/2 Enhanced ReadyPack Reagents
|
| |
|
|
| 2006N-0472
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Substances Prohibited from Use in Animal Food or Feed; Animal Proteins Prohibited in Ruminant Feed
|
| |
|
|
| 2007N-0064
|
| Electronic Case Report Form Submission; Notice of Pilot Project
|
| |
|
|
| 2007N-0069
|
| Animal Drug User Fee Act; Public Meeting
|
| |
|
|
| 2007P-0096
|
| Revoke 21 C.F.R. 165.110(a)(2)(vi), the rule regulating the labeling of bottled water sources
|
| |
|
|
| 2007P-0097
|
| Issue a new regulation wine product the composition of wine , water, sugar, with or without flavorings and an alcohol content of less than 75% can not be marketed or sold with a wine varietal designa
|
|
|
|
|
|
|
| |
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
| |
|
|
| LET 19469
|
| ProHealth, Inc.
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19470
|
| Common Sense Nutrition Company
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19471
|
| Amrita Veda
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19472
|
| The Coromega Company, Inc.
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19473
|
| New Century AAA Inc.
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19474
|
| Little Calumet Holdings, LLC
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19475
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19476
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19477
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19478
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19479
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19480
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19481
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19482
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19483
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19484
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 173
|
|
| | | | | | | | |
|
| |
|
| LET 19485
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19486
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19487
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19488
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 173
|
|
| |
|
| LET 19489
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19490
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19491
|
| CNS, Inc.
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19492
|
| Liv International USA, Inc
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19493
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19494
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19495
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19496
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19497
|
| New Century Company
|
| Vol #:
|
| 173
|
| |
|
|
| LET 19498
|
| NOW Foods
|
| Vol #:
|
| 173
|
| |
|
|
| 2002E-0343
|
| Patent Term Application for Zevalin No. 5,776,456
|
| |
|
|
| CEP 1
|
| U.S. Patent and Trademark Office to Sidley Austin Brown and Wood LPP
|
| Vol #:
|
| 1
|
| |
|
|
| 2003E-0250
|
| Patent Extension for Invanz (ertapenem sodium), 5,478,820
|
| |
|
|
| CEP 1
|
| U.S. Patent and Trademark Office to Merck & Co., Inc.
|
| Vol #:
|
| 1
|
| |
|
|
| 2003E-0254
|
| Patent Extension for Inspra (eplerenone), 4,559,332
|
| |
|
|
| CEP 1
|
| U.S. Patent and Trademark Office to Pharmacia Corporation of Pfizer Inc.
|
| Vol #:
|
| 1
|
| |
|
|
| 2003E-0257
|
| Patent Extension for Neotame, 5,480,668
|
| |
|
|
| CEP 1
|
| U.S. Patent and Trademark Office to Fitzpatrick, Celia, Harper & Scinto
|
| Vol #:
|
| 1
|
|
| |
|
| 2003E-0458
|
| Patent Extension, Velcade, bortezomib, #5,780,454
|
| |
|
|
| CEP 1
|
| U.S. Patent and Trademark Office to Millennium Pharmaceuticals, Inc.
|
| Vol #:
|
| 1
|
| |
|
|
| 2003N-0573
|
| Draft Animal Cloning Risk Assessment
|
| |
|
|
| C 370
|
| J. Baker
|
| Vol #:
|
| 32
|
| |
|
|
| C 371
|
| V. Dunivan
|
| Vol #:
|
| 32
|
| |
|
|
| C 372
|
| M. DeRitis
|
| Vol #:
|
| 32
|
| |
|
|
| C 373
|
| L. Rose
|
| Vol #:
|
| 32
|
| |
|
|
| C 374
|
| L. Davison
|
| Vol #:
|
| 32
|
| |
|
|
| C 375
|
| Y.Fumoto
|
| Vol #:
|
| 32
|
| |
|
|
| C 376
|
| R. Fuentes
|
| Vol #:
|
| 32
|
| |
|
|
| C 377
|
| C. Hobbs
|
| Vol #:
|
| 32
|
|
| | | | | | | | |
|
| |
|
| C 378
|
| C. Azan
|
| Vol #:
|
| 32
|
| |
|
|
| C 379
|
| S. Sevo
|
| Vol #:
|
| 32
|
| |
|
|
| C 380
|
| J. Adrian
|
| Vol #:
|
| 32
|
| |
|
|
| C 381
|
| C. Sackstzka
|
| Vol #:
|
| 32
|
| |
|
|
| C 382
|
| H. McElrath
|
| Vol #:
|
| 32
|
| |
|
|
| C 383
|
| no signature
|
| Vol #:
|
| 32
|
| |
|
|
| C 384
|
| T.Tyler
|
| Vol #:
|
| 32
|
| |
|
|
| C 385
|
| C. Jones
|
| Vol #:
|
| 32
|
| |
|
|
| C 386
|
| M. Stanley
|
| Vol #:
|
| 32
|
| |
|
|
| C 387
|
| D. Schank
|
| Vol #:
|
| 32
|
| |
|
|
| C 388
|
| S. Moreau
|
| Vol #:
|
| 32
|
| |
|
|
| C 389
|
| Genex Cooperative
|
| Vol #:
|
| 32
|
| |
|
|
| C 390
|
| R. Scharlau
|
| Vol #:
|
| 32
|
| |
|
|
| 2004E-0023
|
| Patent extension application 5,849,911 for Reyataz ( atazanavir sulfate )
|
| |
|
|
| CEP 1
|
| U.S. Patent and Trademark Office to Bristol-Myers Squibb Company
|
| Vol #:
|
| 1
|
| |
|
|
| 2004E-0040
|
| Patent Extension for CYDECTIN, U.S. Patent No. 4,916,154
|
| |
|
|
| EXT 1
|
| U.S. Patent and Trademark Office to American Home Products Corporation
|
| Vol #:
|
| 1
|
| |
|
|
| 2005E-0249
|
| Patent Term Extension Application for Enablex, U.S. Patent No. 5,096,890
|
| |
|
|
| CEP 1
|
| U.S. Patent and Trademark Office to Novartis
|
| Vol #:
|
| 1
|
| |
|
|
| 2006M-0384
|
| Premarket Approval: BP050009 / 0 SURE CHECK HIV 1/2 ASSAY
|
| |
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
| |
|
|
| 2006M-0385
|
| Premarket Approval: BP050010 / 0 HIV 1/2 STAT-PAKT ASSAY
|
| |
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
| |
|
|
| 2006M-0386
|
| Premarket Approval: BP050030 / 0 ADVIA Centaur HIV 1/O/2 Enhanced ReadyPack Reagents
|
| |
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
| |
|
|
| 2006N-0472
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Substances Prohibited from Use in Animal Food or Feed; Animal Proteins Prohibited in Ruminant Feed
|
|
|
|
|
|
|
| |
|
|
| N 2
|
| FDA
|
| Vol #:
|
| 1
|
|
| |
|
| 2007N-0064
|
| Electronic Case Report Form Submission; Notice of Pilot Project
|
| |
|
|
| N 1
|
| FDA
|
| Vol #:
|
| 1
|
| |
|
|
| 2007N-0069
|
| Animal Drug User Fee Act; Public Meeting
|
| |
|
|
| NM 1
|
| FDA
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
| |
|
| 2007P-0096
|
| Revoke 21 C.F.R. 165.110(a)(2)(vi), the rule regulating the labeling of bottled water sources
|
| |
|
|
| ACK 1
|
| FDA/DDM to Jennifer McGinn
|
| Vol #:
|
| 1
|
| |
|
|
| CP 1
|
| Jennifer McGinn
|
| Vol #:
|
| 1
|
|
| |
|
| 2007P-0097
|
| Issue a new regulation wine product the composition of wine , water, sugar, with or without flavorings and an alcohol content of less than 75% can not be marketed or sold with a wine varietal designa
|
|
|
|
|
|
|
| |
|
|
| ACK 1
|
| FDA/DDM to Arbor Hill
|
| Vol #:
|
| 1
|
| |
|
|
| CP 1
|
| Arbor Hill
|
| Vol #:
|
| 1
|
|
|
